The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Anti‐interleukin‐6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus
Open accessAbstract
Summary: Systemic lupus erythematosus (SLE) is an autoimmune disease resulting from dysregulation of the immune system. Interleukin‐6 (IL‐6) is a multifunctional cytokine produced by macrophages, monocytes and T and B cells. It stimulates B‐cell differentiation/maturation, immunoglobulin secretion, and T‐cell functions. Elevated levels of IL‐6 in serum, urine and renal glomeruli were detected in patients with active SLE and in murine models of SLE. Our study investigated the role of IL‐6 in an SLE‐like disease in New Zealand Black/White (NZB/W) F 1 mice by administration of an anti‐murine IL‐6 monoclonal antibody (mAb). Intraperitoneal administration of the anti‐IL‐6 mAb suppressed the production of anti‐dsDNA autoantibody. B‐cell proliferation induced by anti‐IgM and anti‐CD40 was lower in the anti‐IL‐6 mAb‐treated mice, ex vivo studies demonstrated that anti‐IL‐6 mAb treatment inhibited anti‐dsDNA production. Anti‐CD3‐induced T‐cell proliferation and mixed lymphocyte reactions were inhibited by anti‐IL‐6 mAb treatment, indicating a partial down‐regulation of T cells. Histological analysis showed that treatment with anti‐IL‐6 mAb prevented the development of severe kidney disease. These results suggest that treatment with anti‐IL‐6 mAb has a beneficial effect on autoimmunity in murine SLE and that autoreactive B cells may be the primary target for anti‐IL‐6 mAb treatment; its effect on autoreactive T cells is also indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Interleukin 6 plays a key role in the development of antigen-induced arthritis
Ohshima, S., Saeki, Y., Mima, T., Sasai, M., Nishioka, K., Nomura, S., Kopf, M., Katada, Y., Tanaka, T., Suemura, M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8222 · Cited by 406
Inhibition of IL-6 for the treatment of inflammatory diseases
NISHIMOTO, N. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.03.005 · Cited by 200
Cited by
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
Yao, X., Huang, J., Zhong, H., Shen, N., Faggioni, R., Fung, M., & Yao, Y. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.004 · Cited by 664
Illei, G. G., Shirota, Y., Yarboro, C. H., Daruwalla, J., Tackey, E., Takada, K., Fleisher, T., Balow, J. E., & Lipsky, P. E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27221 · Cited by 507
Murine Models of Systemic Lupus Erythematosus
Perry, D., Sang, A., Yin, Y., Zheng, Y.-Y., & Morel, L. (2011) · BioMed Research International · doi:10.1155/2011/271694 · Cited by 378
Brooks, W. H., Le Dantec, C., Pers, J.-O., Youinou, P., & Renaudineau, Y. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.12.006 · Cited by 298
Therapeutic Targeting of the Interleukin-6 Receptor
Tanaka, T., Narazaki, M., & Kishimoto, T. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134715 · Cited by 262
Metadata
- Authors
- Liang, B., Gardner, D. B., Griswold, D. E., Bugelski, P. J., & Song, X. Y. R.
- Venue
- Immunology
- Publisher
- Wiley
- Published
- 2006-08-03
- Volume
- 119
- Issue
- 3
- Pages
- 296-305
- ISSN
- 0019-2805 (ISSN-L)
- 1365-2567
- OpenAlex
- W2132738911
- Cited by
- 190
- References
- 3
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti‐interleukin‐6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus. https://app.cochat.ai/papers/10.1111/j.1365-2567.2006.02433.x
- The paper
- Liang, B., Gardner, D. B., Griswold, D. E., Bugelski, P. J., & Song, X. Y. R. (2006). Anti‐interleukin‐6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus. Immunology. https://doi.org/10.1111/j.1365-2567.2006.02433.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.